EU suspends sale of contraceptive implant

August 5, 2017

The sale of a contraceptive implant has been suspended for three months across the European Union after an Irish regulator said it was temporarily withholding renewal of the device's commercial licence.

The National Standards Authority of Ireland said it needed more information before renewing the licence for the Essure contraceptive device, its French counterpart told AFP.

As a result, the device "can no longer be sold in France or Europe during the temporary suspension period," which runs to November, the French ANSM medical safety authority said.

Essure's manufacturers Bayer say the device is a "minimally invasive" permanent birth control procedure.

"We would like to reassure the women who use Essure as their form of contraception and their that the safety and efficacy of Essure continues to be supported by more than a decade of science and real world clinical experience," the company said in a statement.

ANSM urged women to not use the Essure implant in the meantime "as a precaution".

Brazil's public health authority suspended the sale of the device in February pending further testing but lifted the ban last month.

Explore further: Women sue healthcare giant Bayer over contraceptive implants

Related Stories

Women sue healthcare giant Bayer over contraceptive implants

December 9, 2016
French lawyers for women who say a contraceptive implant sold by Bayer Healthcare had caused a string of medical complications launched a lawsuit against the multinational on Friday.

FDA to add bold warning to Essure contraceptive device

February 29, 2016
Federal health regulators plan to add new warnings to Essure, a much-debated contraceptive implant that has been subject to thousands of complaints from women reporting chronic pain, bleeding and other problems.

FDA petitioned to stop sales of essure implant

May 5, 2015
(HealthDay)—Bayer's contraceptive implant Essure can cause serious complications and should be taken off the market, says a citizen's petition filed with the U.S. Food and Drug Administration.

Brazil lifts ban on controversial sterilization implants

July 11, 2017
Brazil has lifted a ban on the sale of Essure female sterilization implants after receiving results from clinical trials on its risks, authorities said Tuesday.

FDA aims to publish Essure safety review in February

November 24, 2015
Federal health officials aim to release their findings on a much-debated contraceptive implant by the end of February.

FDA reviewing safety of Essure birth control implant

June 25, 2015
Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

Recommended for you

Discovery promises improved diagnosis and understanding of endometriosis

March 19, 2018
Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately ...

Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort

March 19, 2018
A clinical trial comparing two treatments for postmenopausal vaginal discomfort - low-dose vaginal estrogen and a vaginal moisturizer - to placebo treatments found that both produced symptom improvements similar to those ...

Frozen embryos more successful for conceiving during IVF

March 19, 2018
A new study carried out by a research team at The University of Western Australia and Fertility Specialists of Western Australia has found that women undergoing IVF who have had embryos fail to implant have more success using ...

Alomst 70 percent of 103 genes linked to prenatal death affect the placenta

March 14, 2018
The role of the placenta in healthy fetal development is being seriously under-appreciated according to a new paper published today (14th March). The study was part of the Wellcome Trust-funded "Deciphering the Mechanisms ...

New research shows why babies need to move in the womb

March 12, 2018
Scientists have just discovered why babies need to move in the womb to develop strong bones and joints. It turns out there are some key molecular interactions that are stimulated by movement and which guide the cells and ...

Labour–inducing drugs put to the test

February 27, 2018
Researchers comparing the use of two drugs for pregnant women who do not go into labour shortly after their waters break have found both are reasonable options.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.